(19)
(11) EP 2 786 767 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.11.2018 Bulletin 2018/48

(45) Mention of the grant of the patent:
03.10.2018 Bulletin 2018/40

(21) Application number: 14174846.7

(22) Date of filing: 10.05.2007
(51) International Patent Classification (IPC): 
A61K 49/00(2006.01)
G01N 33/543(2006.01)
B01L 3/00(2006.01)
 A61K 39/00(2006.01)
G01N 33/569(2006.01)
C12Q 1/70(2006.01)

(54)

Real-time detection of influenza virus

Echtzeit-Detektion des Influenzavirus

Détection en temps réel du virus de la grippe

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 10.05.2006 US 799442 P
16.05.2006 US 800939 P
09.05.2007 US 746535

(43) Date of publication of application:
08.10.2014 Bulletin 2014/41

(60) Divisional application:
18197488.2

(62) Application number of the earlier application in accordance with Art. 76 EPC:
11180769.9 / 2436400
07762092.0 / 2018188

(73) Proprietor: Theranos IP Company, LLC
Newark, CA 94560 (US)

(72) Inventors:
  • Holmes, Elizabeth A.
    Palo Alto, CA 94301 (US)
  • Gibbons, Ian
    Portola Valley, CA 94023 (US)

(74) Representative: Avidity IP 
Broers Building Hauser Forum 21 JJ Thomson Avenue
Cambridge CB3 0FA
Cambridge CB3 0FA (GB)


(56) References cited: : 
WO-A1-2005/031355
US-A1- 2005 100 937
 US-A1- 2002 055 094
   
  • YAN XIAOMEI ET AL: "Multiplexed flow cytometric immunoassay for influenza virus detection and differentiation.", ANALYTICAL CHEMISTRY 1 DEC 2005, vol. 77, no. 23, 1 December 2005 (2005-12-01), pages 7673-7678, XP002527283, ISSN: 0003-2700
  • LEE L JAMES ET AL: "Microfluidic enzyme-linked immunosorbent assay technology", ADVANCES IN CLINICAL CHEMISTRY, ACADEMIC PRESS, LONDON, GB, 1 January 2006 (2006-01-01), pages 255-295, XP008093078, ISSN: 0065-2423
  • PATRICK J GAVIN ET AL: "Review of Rapid Diagnostic Tests for Influenza", CLINICAL AND APPLIED IMMUNOLOGY REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 4, no. 3, 1 January 2003 (2003-01-01) , pages 151-172, XP002503371, ISSN: 1529-1049
  • LIU ROBIN HUI ET AL: "Validation of a fully integrated microfluidic array device for influenza A subtype identification and sequencing.", ANALYTICAL CHEMISTRY 15 JUN 2006, vol. 78, no. 12, 27 April 2006 (2006-04-27), pages 4184-4193, XP002527284, ISSN: 0003-2700
  • L GERENTES ET AL: "A sensitive and specific ELISA immunocapture assay for rapid quantitation of influenza A/H3N2 neuraminidase protein", JOURNAL OF VIROLOGICAL METHODS, vol. 73, no. 2, 1 August 1998 (1998-08-01) , pages 185-195, XP055145122, ISSN: 0166-0934, DOI: 10.1016/S0166-0934(98)00056-1
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).